Kristin Abate, Chief Accounting Officer at Karyopharm Therapeutics, sold KPTI on Oct 16, 2026
Prices as of Oct 16 · price update delayed · Every feed →
▼ SELL$1.6K4,788 shares at $0.34Kristin Abate Chief Accounting OfficerKPTI Karyopharm Therapeutics Inc.
- Traded
- Oct 16, 2026
- Disclosed
- Oct 19, 2026
- Filed
- 3 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
KPTI since disclosure
KPTI has not closed a trading day since the disclosure yet
after the sale
Similar stocks (XLV) since disclosure
KPTI has not closed a trading day since the disclosure yet
XLV — its sector index fund
Our take
None of our tested rules fired on this trade.